#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Restless legs syndrome Glomerulonephritis membranous Follicle centre lymphoma follicular grade I II – III refractory Parkinson's disease Amyloidosis Neurofibromatosis Chondrosarcoma metastatic Primary hyperoxaluria Bronchopulmonary dysplasia Langerhans' cell histiocytosis Neuroendocrine tumour of the lung Extra-osseous Ewing's sarcoma recurrent Candida infection Infantile apnoea Retinal artery occlusion More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Hereditary optic atrophy – Diagnostics Synovial sarcoma recurrent – Treatment Alveolar rhabdomyosarcoma – Basic Information Congenital nephrogenic diabetes insipidus – Trials in Disease Turner’s syndrome – Trials in Disease Combined immunodeficiency Prolymphocytic leukaemia – Life with Disease Sjogren’s syndrome – Diagnostics Uterine leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ebastine Hyoscine Ro7269162 GSKVX000000025896 Betibeglogene Autotemcel Vibegron Ritonavir Contezolid Benfotiamine Tofersen ANTIMETABOLITES 534 Codeine Phosphate Hemihydrate ABBV-CLS-628 Sonidegib Aticaprant Obexelimab SAR445399 Felzartamab Ustekinumab More therapies…

    Learn about Your Condition

    Adenomatous polyposis coli Still's disease Mantle cell lymphoma recurrent Wheezing Bone sarcoma Pyoderma Fallopian tube cancer Palmoplantar pustulosis Renal failure Tissue anoxia Laparotomy Hyperlipidaemia Cardiac failure Marginal zone lymphoma Precocious puberty More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Acute myeloid leukaemia recurrent
    • Acute myeloid leukaemia refractory
    Investigated Drugs:
    • AZD3632
    Denmark Germany Italy

  • Comparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Bevacizumab
    Italy

  • A Study of Belumosudil for Patients with Steroid-Resistant Overlap Syndrome Graft-versus-Host Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Belumosudil Mesilate
    Germany

  • Study of melphalan followed by eribulin, vinorelbine, or capecitabine versus eribulin, vinorelbine, or capecitabine alone for metastatic breast cancer patients with liver disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Melphalan
    • Vinorelbine Tartrate
    • Capecitabine
    France Germany Italy Spain Sweden

  • Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Sotatercept
    Belgium Croatia Czechia Denmark France Germany +7

  • A Study of BCX17725 Safety and Effects in Healthy People and Patients with Netherton Syndrome

    Recruiting

    1 1 1
    France Germany The Netherlands
Previous Page
1 … 90 91 92 93 94 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!